Genextra Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
12
- Portfolio
-
6
- Exits
-
5
Genextra General Information
Description
Founded in 2004, Genextra is a venture capital firm based in Milan, Italy. The firm prefers to invest in early-stage life science companies.
Contact Information
Website
www.genextra.it
Year Founded
2004
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Via Privata Giovannino De Grassi, 11
- 20123 Milan
- Italy
+39 02 0000 0000
Genextra Investments (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| InnovHeart | 27-Jan-2022 | Later Stage VC | 0000 | Therapeutic Devices | Generating Revenue | 00000000 000000 00.0 |
| 0000000000 | 30-Jul-2020 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 00000000 000000 00.0 |
| 0000000000 0000000 | 14-Jul-2020 | 00000 00000 | 00.000 | Pharmaceuticals | Generating Revenue | 00000 0000000 |
| 00000 000000000 | 04-Jun-2020 | 00000 00000 | 00.000 | Drug Discovery | Clinical Trials - Phase 2 | 00000000 000000 00.0 |
| 000000 | 24-Apr-2018 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | 00000 0000000 |
| 000000 | 11-May-2015 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | 00000 0000000 |
| 0000000000 | 01-Jan-2015 | 00000 00000 | Therapeutic Devices | Generating Revenue | 00000 0000000 | |
| 000000000(00000000 | 09-Aug-2012 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 0000000 000000000 00 |
| Intercept(Biotechnology) | 25-Jan-2010 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 0000000 000000000 00 |
| Intercept(Biotechnology) | 29-Jul-2008 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 0000000 000000000 00 |
Genextra Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Congenia | 18-Jun-2021 | Out of Business | |
| 000000000(00000000 | 09-Oct-2015 | 000000000 00000000 | |
| 000000000(00000000 | 18-Jun-2013 | 000000 0000000000 | 000.00 |
| Intercept(Biotechnology) | 11-Oct-2012 | IPO | 0000 |
| Intercept(Biotechnology) | Secondary Transaction - Open Market |
Genextra Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Genextra Team (4)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Paolo Fundaro | Chief Executive Officer | 0 | 0 | Milan, Italy | |
| Francesco Micheli | Founder and Executive Chairman | 0 | Milan, Italy | ||
| Daniele Scarinci | Investment Director | 0 | 0 | Milan, Italy | |
| Federica Draghi Ph.D | Investment Director | 0 | 0 | Milan, Italy |
Genextra Co-Investors (6)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| CDP Venture Capital | 1 | 0 |
|
|
|
| China Grand Pharmaceutical and Healthcare Holdings | 0 | 0 |
|
|
|
| Innogest Capital | 0 | 0 |
|
|
|
| Panakes Partners | 0 | 0 |
|
|
|
| Sofinnova Partners | 0 | 0 |
|
|